Comments on Drug Channels: The DEA's Anti-Diversion Strategy

Dr. Fein: You can't blame Cardinal's management fo...

2008-03-14T10:25:00.000-04:00

Dr. Fein: You can't blame Cardinal's management for whats going on with the DEA because the DEA is making an example of Cardinal. I agree that they have not handled the situation with their pharmacies very well but they don't have much choice.

Here are clickable links for the previous two comm...

2008-03-14T10:22:00.000-04:00

Here are clickable links for the previous two comments:

Richie Pharmacal, Inc.

Federal Register notice for Southwood Pharmaceuticals

Thanks to my helpful readers!

Adam

Hello Adam,I’d prefer to not have my name / compan...

2008-03-14T10:19:00.000-04:00

Hello Adam,

I’d prefer to not have my name / company listed, but I believe the last (7th) license suspension you are looking for is Richie Pharmacal, Inc. Glasgow, KY (2007).

Here’s the Federal Register Notice for Southwood.h...

2008-03-14T10:18:00.000-04:00

Here’s the Federal Register Notice for Southwood.

http://www.deadiversion.usdoj.gov/fed_regs/actions/2007/fr07032.htm

I've just received some emails pointing me to two ...

2008-03-14T09:19:00.000-04:00

I've just received some emails pointing me to two of the other three suspensions.

Here's what I have so far:

Southwood Pharmaceuticals

Bellco Drug Corporation

Bellco was acquired by AmerisourceBergen in 2007. Here's the text from ABC's most recent 10-K:
"On October 1, 2007, we acquired Bellco Health, a privately held New York distributor of branded and generic pharmaceuticals. Bellco Health consists of two companies, Bellco Drug Corp. and American Medical Distributors, Inc. (“AMD”). The DEA registration of Bellco Drug was suspended in May 2007 prior to our acquisition of the business. AMD’s registration was not suspended but both AMD and Bellco Drug received an order to show cause why their registrations should not be revoked . The suspension of Bellco Drug’s registration and the order to show cause were based on Bellco Drug’s alleged failures to maintain effective controls against the diversion of controlled substances as required by federal law. In June 2007, Bellco Drug entered into a consent judgment with the DEA in which Bellco Drug expressly denied the allegations of diversion and agreed to voluntarily surrender its DEA registration with leave to apply for a new registration. The administrative proceeding on the order to show cause relating to AMD’s DEA registration was also dismissed at that time pursuant to a separate memorandum of understanding between AMD and DEA, which allowed AMD to continue serving its customers and to expand its DEA registration so that AMD could service Bellco Drug’s Metro New York City customers. Bellco Drug has applied for a new DEA registration. As a result of our acquisition of Bellco Health and our own settlement agreement with the DEA, we expect that the Bellco Drug application for a new DEA registration may be subject to particular review and scrutiny by the DEA. Denial by the DEA of Bellco Drug’s application for a new registration could adversely affect Bellco Health’s operations and ability to conduct business in the ordinary course and, therefore, could adversely affect both the value of the businesses that we just acquired and our overall results of operations."

Adam

Look up Southwood Pharmaceuticals.

2008-03-14T09:08:00.000-04:00

Look up Southwood Pharmaceuticals.